Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

The associations between plasma letrozole concentrations and CYP2A6 and CYP3A5 genetic variants were tested in the Exemestane and Letrozole Pharmacogenomics (ELPH) trial. ELPH is a multicenter, open-label prospective clinical trial in women randomly assigned (n ≈ 250 in each arm) to receive 2 years...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Desta, Z, Kreutz, Y, Nguyen, AT, Li, L, Skaar, T, Kamdem, LK, Henry, NL, Hayes, DF, Storniolo, AM, Stearns, V, Hoffmann, E, Tyndale, RF, Flockhart, DA
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667657/
https://ncbi.nlm.nih.gov/pubmed/21975350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2011.174
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars